Background It has been reported that people with COVID‐19 and pre‐existing
autoantibodies against type I interferons are likely to develop an inflammatory cytokine storm …

Background Viral epidemics or pandemics of acute respiratory infections (ARIs) pose a
global threat. Examples are influenza (H1N1) caused by the H1N1pdm09 virus in 2009 …

Most public health measures to contain the COVID-19 pandemic are based on preventing
the pathogen spread, and the use of oral antiseptics has been proposed as a strategy to …

Summary Angiotensin converting enzyme 2 (ACE2) is the cellular receptor for SARS-CoV-2,
so ACE2-expressing cells can act as target cells and are susceptible to infection. ACE2 …

Abstract Objective Coronavirus disease 2019 (COVID-19) caused by infection by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide. Since …

Background Many people infected with severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) never develop substantial symptoms. With more than 34 million people in the …

Objectives Aerosols and splatter are routinely generated in dental practice and can be
contaminated by potentially harmful bacteria or viruses such as SARS-CoV-2. Therefore …

The SARS-CoV-2 virus has shaken the globe with an ongoing pandemic of COVID-19 and
has set challenges to every corner of the modern health care setting. The oral mucosa and …

Cetylpyridinium chloride (CPC), a quaternary ammonium compound, which is present in
mouthwash, is effective against bacteria, fungi, and enveloped viruses. This study was …

The airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) via respiratory fluids and droplets suggests that mouthwashes containing substances with …